NOMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nomad Foods Ltd (NOMD) is not a strong buy for a beginner investor with a long-term focus. The company's recent financial performance is weak, with declining revenue, net income, and EPS. Analyst ratings have shown a trend of lowered price targets and cautious sentiment due to input cost pressures and limited pricing power. Technical indicators suggest a bearish trend, and there are no significant positive catalysts in the news or trading trends. While options data shows a bullish sentiment with low put-call ratios, this is insufficient to outweigh the negative fundamentals and analyst concerns. Holding off on investment until the company's financials and market conditions improve is recommended.
The technical indicators for NOMD suggest a bearish trend. The MACD is positive but contracting, RSI is neutral at 37.013, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels indicate a pivot at 9.733, with resistance at 9.947 and support at 9.519. The stock is currently trading near its support level.
Options data shows a bullish sentiment with a low put-call ratio, indicating more interest in calls than puts.
Weak financial performance in Q4 2025, with revenue down -2.56% YoY, net income down -120.82% YoY, and EPS down -121.88% YoY. Analysts have downgraded the stock and lowered price targets due to cost pressures and limited pricing power. No recent positive news or significant trading trends from hedge funds or insiders.
In Q4 2025, Nomad Foods reported declining financials: revenue dropped to $773.1M (-2.56% YoY), net income fell to -$10.7M (-120.82% YoY), and EPS decreased to -0.07 (-121.88% YoY). Gross margin also dropped to 25.57%, down -10.19% YoY.
Analyst sentiment is cautious. Barclays lowered its price target to $12 from $13, citing concerns about input costs and dividend sustainability. Deutsche Bank downgraded the stock to Hold with a price target of $10, citing cost pressures and demand headwinds. Other firms have also reduced price targets, reflecting a negative outlook for the company.
